419. Viral SARS-CoV-2 rebound rates in linked commercial pharmacy-based SARS-CoV-2 RT-qPCR testing and healthcare claims

por Luo, Shishi, McEwen, Lisa M, Kelly, Scott P, Isaksson, Magnus, Murphy, Sarah, White, Simon, McCrone, J T, Levan, Geraint, Santhanam, Sharad, Baniecki, Mary Lynn, Bramson, Candace, Rubino, Heather, Hendrick, Victoria, Soares, Holly, Hammond, Jennifer
Publicado 2023

Genomics-informed outbreak investigations of SARS-CoV-2 using civet

por O’Toole, Áine, Hill, Verity, Jackson, Ben, Dewar, Rebecca, Sahadeo, Nikita, Colquhoun, Rachel, Rooke, Stefan, McCrone, J. T., Duggan, Kate, McHugh, Martin P., Nicholls, Samuel M., Poplawski, Radoslaw, Aanensen, David, Holden, Matt, Connor, Tom, Loman, Nick, Goodfellow, Ian, Carrington, Christine V. F., Templeton, Kate, Rambaut, Andrew
Publicado 2022

The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK

por Hill, Verity, Du Plessis, Louis, Peacock, Thomas P, Aggarwal, Dinesh, Colquhoun, Rachel, Carabelli, Alesandro M, Ellaby, Nicholas, Gallagher, Eileen, Groves, Natalie, Jackson, Ben, McCrone, J T, O’Toole, Áine, Price, Anna, Sanderson, Theo, Scher, Emily, Southgate, Joel, Volz, Erik, Barclay, Wendy S, Barrett, Jeffrey C, Chand, Meera, Connor, Thomas, Goodfellow, Ian, Gupta, Ravindra K, Harrison, Ewan M, Loman, Nicholas, Myers, Richard, Robertson, David L, Pybus, Oliver G, Rambaut, Andrew
Publicado 2022